相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel conditioning regimen for upfront haploidentical hematopoietic cell transplantation in children with severe aplastic anemia and donor-specific anti-HLA antibodies
Hasan Hashem et al.
BONE MARROW TRANSPLANTATION (2022)
Pre-transplant myeloid and immune suppression, upfront plerixafor mobilization and post-transplant cyclophosphamide: novel strategy for haploidentical transplant in sickle cell disease
Gaurav Kharya et al.
BONE MARROW TRANSPLANTATION (2021)
Clinical Outcome of Acquired Post-Immunosuppressive-Therapy Aplastic Anemia in Pediatric Patients: A 13-Year Experience in Two Southern China Tertiary Care Centers
Junbin Huang et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
Benjamin Watkins et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Pretransplant myeloid and immune suppression, reduced toxicity conditioning with posttransplant cyclophosphamide: Initial outcomes of novel approach for matched unrelated donor hematopoietic stem cell transplant for hemoglobinopathies
Gaurav Kharya et al.
PEDIATRIC BLOOD & CANCER (2021)
Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6-7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years
Xia Qin et al.
ANNALS OF HEMATOLOGY (2021)
Haploidentical Peripheral Stem Cell Transplantation for Young Patients with Severe Aplastic Anemia Using Post-Transplantation Cyclophosphamide and Methotrexate
Kaitai Yang et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party
Pedro H. Prata et al.
BONE MARROW TRANSPLANTATION (2020)
CTLA4Ig in an Extended Schedule along with Sirolimus Improves Outcome with a Distinct Pattern of Immune Reconstitution Following Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation for Hemoglobinopathies
Sarita Rani Jaiswal et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide
Amy E. DeZern et al.
BLOOD ADVANCES (2020)
Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia
Leonardo Javier Arcuri et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Upfront Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide in Children With Severe Aplastic Anemia
Satya P. Yadav et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2020)
Incidence and treatment outcome of aplastic anemia in Taiwanreal-world data from single-institute experience and a nationwide population-based database
Sin-Syue Li et al.
ANNALS OF HEMATOLOGY (2019)
Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study
Lan-Ping Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases
Monica S. Thakar et al.
BLOOD (2019)
Post-Transplant Cyclophosphamide as Sole Graft-versus-Host Disease Prophylaxis Is Feasible in Patients Undergoing Peripheral Blood Stem Cell Transplantation for Severe Aplastic Anemia Using Matched Sibling Donors
Biju George et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most
Bronwen E. Shaw et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation
Stefan O. Ciurea et al.
BONE MARROW TRANSPLANTATION (2018)
First-line choice for severe aplastic anemia in children: Transplantation from a haploidentical donor vs immunosuppressive therapy
Yifei Cheng et al.
CLINICAL TRANSPLANTATION (2018)
Therapeutic Outcomes of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Multicenter Study
Yonghua Li et al.
TRANSPLANTATION (2018)
Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: A large-sample study from China
Yunjing Zeng et al.
SCIENTIFIC REPORTS (2018)
Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia
L. P. Xu et al.
BONE MARROW TRANSPLANTATION (2017)
Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant
Lan-Ping Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
High incidence of aplastic anemia is linked with lower socioeconomic status of Indian population
Pankaj Malhotra et al.
JOURNAL OF PUBLIC HEALTH (2016)
Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions
Rajat Kumar et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia
S-E Lee et al.
BONE MARROW TRANSPLANTATION (2016)
Transplantation for bone marrow failure: current issues
Regis Peffault de Latour
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP)
Angelica Barone et al.
BLOOD CELLS MOLECULES AND DISEASES (2015)
Pre-transplant sirolimus might improve the outcome of haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide for patients with severe aplastic anemia
S. R. Jaiswal et al.
BONE MARROW TRANSPLANTATION (2015)
Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant
Carlo Dufour et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT
Carlo Dufour et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy
L. Gao et al.
BONE MARROW TRANSPLANTATION (2014)
Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children
Dae Chul Jeong et al.
HAEMATOLOGICA (2014)
Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group
Jing Chen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia
Nack-Gyun Chung et al.
PEDIATRIC TRANSPLANTATION (2013)
Matched Sibling Versus Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation in Children with Severe Acquired Aplastic Anemia: Experience of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation
Dawid Szpecht et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2012)
Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups
Andrea Bacigalupo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Donor Characteristics Affecting Graft Failure, Graft-versus-Host Disease, and Survival after Unrelated Donor Transplantation with Reduced-Intensity Conditioning for Hematologic Malignancies
Jakob R. Passweg et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Influence of Nucleated Cell Dose on Overall Survival of Unrelated Cord Blood Transplantation for Patients with Severe Acquired Aplastic Anemia: A Study by Eurocord and the Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation
Regis Peffault de Latour et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Clonal Evolution in Aplastic Anemia
Manuel G. Afable et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2011)
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS SUPERIOR TO IMMUNOSUPPRESSIVE THERAPY IN INDIAN CHILDREN WITH APLASTIC ANEMIA-A SINGLE-CENTER ANALYSIS OF 100 PATIENTS
Biju George et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2010)
Guidelines for the diagnosis and management of aplastic anaemia
Judith C. W. Marsh et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Unrelated cord blood transplantation for severe aplastic anemia
Ayami Yoshimi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
The epidemiology of acquired aplastic anemia
Neal S. Young et al.
HAEMATOLOGICA (2008)
Epidemiology of aplastic anemia: a prospective multicenter study
Eva Montane et al.
HAEMATOLOGICA (2008)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
分享论文
